Division of Pharmaceutical Sciences, The University of Missouri School of Pharmacy, Kansas City, Missouri 64110-2499, USA.
Mol Pharm. 2010 Feb 1;7(1):169-76. doi: 10.1021/mp900195c.
The main object of this study was to evaluate the role of intracellular free calcium ion Ca2+ in monocarboxylate transporter (MCT) mediated drug uptake by HeLa cells. It was hypothesized that alterations in the Ca2+ levels affect Na+-H+ exchanger (NHE) regulated pH(in) and thereby produce the proton-motivated driving force for monocarboxylate mediated substrate transport. The changes in intracellular pH (pH(in)) and MCT mediated uptake rates of L-lactic acid by HeLa cells, a human cervical adenocarcinoma cell line, were evaluated under the conditions, whose Ca2+ concentrations were altered by various calcium modulators, such as EGTA-AM (a chelator), nifedipine (a Ca2+ channel antagonist) and A23187 (an ionophore). For the purpose of comparison, the L-lactic acid uptake by HeLa cells was also evaluated under various pH(in) conditions induced by dexamethasone. The effects of the extracellular sodium concentration on the L-lactic acid uptake by HeLa cells were evaluated to determine the involvement of NHE-regulated pH changes in the MCT mediated drug uptake process. The Ca2+ concentrations and pH(in) in HeLa were assessed using fluorescent probes fura-2 and 2',7'-bis[2-carboxyethyl-5-carboxyfluorescein] (BCECF), respectively. The treatment of HeLa cells with A23187 at concentrations of 50 and 100 microM enhanced Ca2+ by 100% and 200% of the control, respectively. EGTA/AM (50 microM) or nifedipine (100 microM) did not cause any significant changes in the Ca2+ levels, whereas EGTA/AM (100 microM) and nifedipine (200 microM) reduced the Ca2+ levels by 30% and 25%, respectively, as compared with the control. A23187 at a concentration of 100 microM in the incubation medium lowered pH(in) (pH 5) and subsequently the uptake rate of lactic acid by 50% (0.47 +/- 0.03 micromol/mg protein/min) of the control. In contrast, nifedipine (200 microM) and EGTA-AM (100 microM), the calcium modulators that lowered the Ca2+ levels and maintained the higher pH(in) (pH > 6) of HeLa cells, enhanced the uptake rate of lactic acid by 60% and 130% of the control, respectively. The results of this study demonstrated that there was a close correlation between the Ca2+ level and pH(in) and that NHEs were involved with the MCT mediated uptake process in HeLa cells. An understanding of the role of Ca2+ in the MCT mediated transport process could provide an efficient strategy to improve the systemic delivery of monocarboxylate substrates through the cervical mucosa.
本研究的主要目的是评估细胞内游离钙离子(Ca2+)在 HeLa 细胞单羧酸转运蛋白 (MCT) 介导的药物摄取中的作用。假设 Ca2+水平的变化会影响 Na+-H+交换器 (NHE) 调节的 pH(in),从而产生单羧酸介导的底物转运的质子动力。通过各种钙调节剂(如 EGTA-AM(螯合剂)、硝苯地平(钙通道拮抗剂)和 A23187(离子载体))改变 Ca2+浓度,评估 HeLa 细胞(人宫颈腺癌细胞系)的细胞内 pH (pH(in))和 L-乳酸的 MCT 介导摄取率。为了进行比较,还评估了 HeLa 细胞在由地塞米松诱导的各种 pH(in)条件下对 L-乳酸的摄取。评估细胞外钠离子浓度对 HeLa 细胞摄取 L-乳酸的影响,以确定 NHE 调节的 pH 变化在 MCT 介导的药物摄取过程中的参与。使用荧光探针 fura-2 和 2',7'-双[2-羧乙基-5-羧基荧光素](BCECF)分别评估 HeLa 中的 Ca2+浓度和 pH(in)。用 A23187(50 和 100 microM)处理 HeLa 细胞可分别将 Ca2+提高 100%和 200%对照水平。EGTA/AM(50 microM)或硝苯地平(100 microM)不会导致 Ca2+水平发生任何显着变化,而 EGTA/AM(100 microM)和硝苯地平(200 microM)分别使 Ca2+水平降低 30%和 25%与对照相比。孵育培养基中浓度为 100 microM 的 A23187 降低 pH(in)(pH 5),随后乳酸摄取率降低 50%(0.47 +/- 0.03 微摩尔/毫克蛋白/分钟)对照。相比之下,硝苯地平(200 microM)和 EGTA-AM(100 microM)降低 Ca2+水平并维持 HeLa 细胞较高的 pH(in)(pH > 6),分别将乳酸摄取率提高 60%和 130%对照。本研究的结果表明,Ca2+水平与 pH(in)之间存在密切相关性,NHE 参与了 HeLa 细胞中 MCT 介导的摄取过程。了解 Ca2+在 MCT 介导的转运过程中的作用可以为通过宫颈黏膜提高单羧酸底物的全身递送提供一种有效的策略。